← SynDRA
MITIGLINIDE
SynDRA canonical compound SYN0011603 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ABCC8 |
|---|
| Mechanism of action | Insulin secretagogue |
|---|
| Indication | diabetes mellitus |
|---|
| Disease area | endocrinology |
|---|
All known targets
- ABCC8
- KCNJ11
- KCNJ10
- INS
- PPARG
Mechanisms of action (all sources)
- Insulin secretagogue
- KCNJ11 BLOCKER
- Sulfonylurea receptor 1, Kir6.2 blocker
- ABCC8 BLOCKER
- KCNJ10 BLOCKER
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR1
- ACMSD
- HTR1A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MC4R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HTR2A
- HRH2
- ADORA1
- AVPR2
- ADORA2A
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- BDKRB2
Drug classes
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- mitiglinide calcium
- mitiglinide calcium hydrate
- S 21403
- KAD-1229
- Mitiglinida
- Mitiglinide calcium
- Mitiglinide calcium hydrate
- Kad-1229
- S21403
- Glufast (TN)
- Calcium 2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate dihydrate
- Calcium (2S)-4-[(3aS,7aR)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoate
- (2S)-4-[(3aR,7aS)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoic acid
- 2-Benzyl-3-(hexahydro-2-isoindolinylcarbonyl)propionate
- mitiglinida
- D86I0XLB13
- mitiglinidum
- miti-glinide
- RefChem:159078
- DTXCID2028278
- A10BX08
- Mitiglinide [INN]
- MITIGLINIDE [MI]
- MITIGLINIDE [MART.]
- UNII-D86I0XLB13
- SCHEMBL49085
- MITIGLINIDE [WHO-DD]
- orb1705059
- CHEBI:135349
- WPGGHFDDFPHPOB-BBWFWOEESA-N
- HY-B0682
- AC-632
- AKOS025149480
- CS-0009585
- NS00068476
- T21431
- BRD-K52959329-238-01-9
- 9I0
Look up MITIGLINIDE in the interactive SynDRA portal →